Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Am J Hum Genet ; 93(5): 957-66, 2013 Nov 07.
Article in English | MEDLINE | ID: mdl-24207120

ABSTRACT

Many ion channel genes have been associated with human genetic pain disorders. Here we report two large Chinese families with autosomal-dominant episodic pain. We performed a genome-wide linkage scan with microsatellite markers after excluding mutations in three known genes (SCN9A, SCN10A, and TRPA1) that cause similar pain syndrome to our findings, and we mapped the genetic locus to a 7.81 Mb region on chromosome 3p22.3-p21.32. By using whole-exome sequencing followed by conventional Sanger sequencing, we identified two missense mutations in the gene encoding voltage-gated sodium channel Nav1.9 (SCN11A): c.673C>T (p.Arg225Cys) and c.2423C>G (p.Ala808Gly) (one in each family). Each mutation showed a perfect cosegregation with the pain phenotype in the corresponding family, and neither of them was detected in 1,021 normal individuals. Both missense mutations were predicted to change a highly conserved amino acid residue of the human Nav1.9 channel. We expressed the two SCN11A mutants in mouse dorsal root ganglion (DRG) neurons and showed that both mutations enhanced the channel's electrical activities and induced hyperexcitablity of DRG neurons. Taken together, our results suggest that gain-of-function mutations in SCN11A can be causative of an autosomal-dominant episodic pain disorder.


Subject(s)
Pain/genetics , Animals , Asian People/genetics , Calcium Channels/genetics , Female , Ganglia, Spinal/metabolism , Ganglia, Spinal/pathology , Genetic Linkage , Genetic Markers , Humans , Male , Mice , Microsatellite Repeats , Mutation, Missense , NAV1.7 Voltage-Gated Sodium Channel/genetics , NAV1.9 Voltage-Gated Sodium Channel/genetics , Nerve Tissue Proteins/genetics , Neurons/metabolism , Neurons/pathology , Pain/pathology , Pedigree , TRPA1 Cation Channel , Transient Receptor Potential Channels/genetics
2.
J Invest Dermatol ; 141(3): 533-544, 2021 03.
Article in English | MEDLINE | ID: mdl-32795530

ABSTRACT

Pilomatricoma, a benign skin appendage tumor, also known as calcifying epithelioma, consists of islands of epithelial cells histologically that contain anucleated cells in the center surrounded by basophilic cells and partial calcification. Sporadic pilomatricomas commonly have somatic mutations in the gene CTNNB1, but causative genes from germline and the underlying pathophysiology are unclear. In this study, we identified a germline missense variant of PLCD1 encoding PLCδ1, c.1186G>A (p.Glu396Lys), in a large Chinese family with autosomal dominant multiple pilomatricomas. Phospholipase C, a key enzyme playing critical roles in intracellular signal transduction, is essential for epidermal barrier integrity. The p.Glu396Lys variant increased the enzymatic activity of PLCδ1, leading to protein kinase C/protein kinase D/extracellular signal-regulated kinase1/2 pathway activation and TPRV6 channel closure, which not only resulted in excessive proliferation of keratinocytes in vitro and in vivo but also induced local accumulation of calcium in the pilomatricoma-like tumor that developed spontaneously in the skin of Plcd1E396K/E396K mice. Our results implicate this p.Glu396Lys variant of PLCD1 from germline leading to gain-of-function of PLCδ1 as a causative genetic defect in familial multiple pilomatricomas.


Subject(s)
Calcium Channels/metabolism , Hair Diseases/genetics , Phospholipase C delta/genetics , Pilomatrixoma/genetics , Skin Neoplasms/genetics , TRPV Cation Channels/metabolism , Animals , DNA Mutational Analysis , Disease Models, Animal , Female , Germ-Line Mutation , Hair Diseases/pathology , Humans , MAP Kinase Signaling System/genetics , Male , Mice, Transgenic , Middle Aged , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Mutation, Missense , Pedigree , Pilomatrixoma/pathology , Protein Kinase C/metabolism , Skin/pathology , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL